Researchers have discovered how IBD activates the bone marrow and increases the risk of colon cancer through a key TL1A signal.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present 38 abstracts, as well as one oral presentation in ...

URBANA, Ill. (WCIA) — The American Cancer Society is updating its guidelines to include a new screening for the most ...

Bondi said she is still recovering after surgery but "doing well." ...

Every person should be aware of cancer; before it develops, people should undergo related tests every year,” warned surgical ...

WHAT: Researchers from the Johns Hopkins Kimmel Cancer Center will present new research findings and receive honors and ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its FDA-approved Shield™ blood test is now included in updated American Cancer Society (ACS) Colorectal Cancer ...

After the popular Lee’s Summit coach’s successful colon cancer surgery, his story and community support highlight screening ...

Colon cancer symptoms often don't exist. An active woman shares how repeated nudges from a loved one led to her diagnosis: "My entire life changed that day." ...

A cell copies all of its DNA, gears up to split in two, and then just… doesn’t. It sits there, swollen with a double genome, ...

Most significant change years in pancreatic cancer drug demand drives Mayo Clinic and others to expand access and patient education on daraxonrasib.

Shuler, who was recently diagnosed with Hodgkin lymphoma, knows he has a tough road ahead. But he has a supporter in a former ...